 |
|
Dyspepsia in the Community Is Linked to Smoking and Aspirin Use but Not to Helicobacter pylori Infection
Sanjay Nandurkar, FRACP;
Nicholas J. Talley, MD, PhD, FRACP;
Harry Xia, PhD;
Hazel Mitchell, PhD;
Stuart Hazel, PhD;
Michael Jones, PhD
Arch Intern Med. 1998;158:1427-1433.
Background The relationship between Helicobacter pylori infection and symptoms remains controversial. We aimed to determine if an association exists between unexplained dyspepsia (pain or discomfort centered in the upper part of the abdomen) and H pylori.
Methods A validated questionnaire was completed by 592 healthy blood donors. Helicobacter pylori serologic values (via enzyme-linked immunosorbent assay), blood group status, and Rh status were measured; 4.9% of subjects who had a history of peptic ulcer disease were excluded from the analyses.
Results The prevalence of dyspepsia and no ulcer history was 11% (95% confidence interval [CI], 8.6%-13.8%); 15.4% of subjects with dyspepsia had H pylori while 14.6% of subjects without dyspepsia were infected (P=.90). The mean dyspepsia impact scores (combining frequency and severity) in those with and without H pylori were 4.7 and 5.4, respectively (P=.20). The median H pylori optical density values in dyspepsia vs no dyspepsia were not significantly different (P=.30). Independent risk factors for dyspepsia were the use of aspirin (odds ratio [OR], 2.2; 95% CI, 1.3-3.7) and smoking (OR, 2.1; 95% CI, 1.3-3.6) but not age, sex, marital status, educational level, income, or the use of alcohol, coffee, or nonsteroidal anti-inflammatory drugs. Independent risk factors for H pylori were increasing age (OR, 1.8 per decade; 95% CI, 1.5-2.3), male sex (OR, 2.1; 95% CI, 1.3-3.4), and net family income (OR, 1.8; 95% CI, 1.2-3.3).
Conclusion Dyspepsia in the community is linked to smoking and aspirin use, but not to H pylori infection.
From the Department of Medicine, University of Sydney (Drs Nandurkar, Talley, and Xia), the Department of Microbiology, University of New South Wales (Drs Mitchell and Hazel), and Instat Australia, Sydney (Dr Jones), Australia.
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Dyspepsia in general practice: incidence, risk factors, comorbidity and mortality
Wallander et al.
Fam Pract 2007;24:403-411.
ABSTRACT
| FULL TEXT
Gastroenterology services in the UK. The burden of disease, and the organisation and delivery of services for gastrointestinal and liver disorders: a review of the evidence
Williams et al.
Gut 2007;56:1-113.
FULL TEXT
Hospitalization for gastrointestinal bleeding associated with non-steroidal anti-inflammatory drugs among elderly patients using low-dose aspirin: a retrospective cohort study
Rahme et al.
Rheumatology (Oxford) 2007;46:265-272.
ABSTRACT
| FULL TEXT
Itopride for functional dyspepsia.
Taylor et al.
NEJM 2006;354:2392-2392.
FULL TEXT
Effect of Helicobacter pylori eradication on development of dyspeptic and reflux disease in healthy asymptomatic subjects
Vaira et al.
Gut 2003;52:1543-1547.
ABSTRACT
| FULL TEXT
Unexpected Decrease with Age of Helicobacter pylori Seroprevalence among Swedish Blood Donors
Sorberg et al.
J. Clin. Microbiol. 2003;41:4038-4042.
ABSTRACT
| FULL TEXT
An evidence-based approach to the management of uninvestigated dyspepsia in the era of Helicobacter pylori
van Zanten et al.
CMAJ 2000;162:s3-23.
ABSTRACT
| FULL TEXT
Systematic Review of the Epidemiological Evidence on Helicobacter pylori Infection and Nonulcer or Uninvestigated Dyspepsia
Danesh et al.
Arch Intern Med 2000;160:1192-1198.
ABSTRACT
| FULL TEXT
Eradication of Helicobacter pylori in functional dyspepsia: randomised double blind placebo controlled trial with 12 months' follow up
Talley et al.
BMJ 1999;318:833-837.
ABSTRACT
| FULL TEXT
|
